The new partnership will produce more funds for NHS patient services
The Christie and HCA International Limited have agreed a £14 million joint venture to develop a new private patient cancer centre.
The Christie - which is based in Manchester and is Europe’s largest cancer centre - plans to increase income for its NHS developments through joining forces with HCA - which is the UK’s largest provider of cancer care services outside the NHS.
The partnership agreement will cover all areas of cancer treatment and care including surgery, chemotherapy, haemato-oncology, (including transplants) and radiotherapy and will be called ‘The Christie Clinic’.
The Christie’s income from private patients has grown by over 14% since 2005 to around £10 million per year - representing around 6% of the cancer centre’s total £173 million income. This partnership will expand the range of private cancer services in the North of England through substantial investment in a new private cancer centre, and state-of-the-art cancer diagnostics, surgical cancer services, chemotherapy and radiotherapy. These new services will be provided from the new centre from 2013 onwards. The Christie Clinic will become part of HCA’s Leaders in Oncology Care network.
Caroline Shaw, chief executive of The Christie, said, “We are delighted to be working with HCA who have an outstanding track-record of providing high quality cancer care.
“This partnership will provide a world-class cancer service for private patients, but importantly it will also enable us to enhance our NHS services. Our profit from The Christie Clinic will go into caring for our NHS patients.”
Mr Michael Neeb, President and Chief Executive Officer of HCA International Limited said the agreement with The Christie was a milestone for private patient cancer care in the UK. “Two dynamic organisations are joining forces to combine the unique strengths of both parties to create this new facility for private patients from all over the North of England,” he said.
“The Christie is an international leader in cancer research and I am very excited that we have been able to reach agreement to develop our first joint venture cancer centre outside London and the South East,” he said. “Both of our organisations have the same commitment to provide the highest standards of care and we intend that this joint venture will ultimately benefit both private and NHS patients,” said Mr Neeb.